Akebia Therapeutics Inc (AKBA)
Operating Income Growth
-144.90%
Quarterly · Period ending:
AKBA Operating Income Growth
Year-over-year change vs the same period a year earlier
Latest reported-144.90%period ending
Latest reported-144.90%period ending
AKBA Quarterly Operating Income YoY % (-232.71% → -144.90%)
Year-over-year change
High-resolution chart · PNG
AKBA operating income growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Income Growth |
|---|---|
| -144.9003% | |
| -134.7491% | |
| 40.2181% | |
| 135.5778% | |
| 261.4785% | |
| 190.4794% | |
| -1,141.2664% | |
| 4.0733% | |
| 3.0124% | |
| 41.6494% | |
| 121.6378% | |
| 74.1375% | |
| -126.4006% | |
| 56.2392% | |
| 90.2815% | |
| 8.1642% | |
| 142.9475% | |
| 9.9221% | |
| 23.4933% | |
| 5.5237% | |
| 54.3542% | |
| -9.8283% | |
| 9.9988% | |
| -3.9174% | |
| -192.0199% | |
| 22.1722% | |
| -5.2754% | |
| -100.7866% | |
| -66.9088% | |
| -210.1029% | |
| -892.9621% | |
| -15.1679% | |
| -61.1041% | |
| 45.5261% | |
| 129.8786% | |
| 33.1822% | |
| 38.8306% | |
| -72.6637% | |
| -89.7456% | |
| -83.8703% | |
| -232.3354% | |
| -139.0419% | |
| -89.0261% | |
| -105.3214% | |
| -38.8904% | |
| -9.9579% | |
| -71.047% | |
| -137.5806% | |
| -151.2189% | |
| -284.5685% | |
| -232.7062% |